Quality of Life of Patients With a History of Drug Allergy in Thailand

Quality of life of patients with a history of drug allergy in Thailand will be studied.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Quality of Life

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

About this study

Thai patients with a history of drug allergy will be evaluated for their quality of life based on drug hypersensitivity quality of life questionnaire (DrHy-Q; Thai version) and The World Health Organization Quality of Life instrument (WHOQOL-BREF-THAI)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Have a history of drug allergy
At least 18 years of age

Exclusion criteria

Not be able to understand Thai language

Treatment and study plan

questionnaires

Other

DrHy-Q (Thai version) and WHOQOL-BREF-THAI will be asked

Primary outcomes

The quality of life of Thai patients with a history of drug allergy evaluating by DrHy-Q (Thai version)

Time frame: 1 year

Secondary outcomes

The correlation between DrHy-Q (Thai version) and WHOQOL-BREF-THAI

Time frame: 1 year

Pearson correlation coefficient between scores from DrHy-Q (Thai version) and WHOQOL-BREF-THAI in patients with a history of drug allergy will be analyzed.

Sponsors and collaborators

Lead sponsor

Chulalongkorn University

Other

Collaborators

Mahidol University

Registry information

Important dates

Study start: 2012
Primary completion: 2017
Study completion: 2017
First posted: Aug 16, 2012
Registry last updated: Feb 18, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed